Home LiteratureArticle Details
PMID: 12351399 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Mechanisms of CD47-induced caspase-independent cell death in normal and leukemic cells: link between phosphatidylserine exposure and cytoskeleton organization.

Blood ·Vol. 100 ·No. 8 ·2002-10-15 ·Pages 2882-90

Mateo V, Brown EJ, Biron G, Rubio M, Fischer A, Deist FL, Sarfati M

Abstract

Dying cells, apoptotic or necrotic, are swiftly eliminated by professional phagocytes. We previously reported that CD47 engagement by CD47 mAb or thrombospondin induced caspase-independent cell death of chronic lymphocytic leukemic B cells (B-CLL). Here we show that human immature dendritic cells (iDCs) phagocytosed the CD47 mAb-killed leukemic cells in the absence of caspases 3, 7, 8, and 9 activation in the malignant lymphocytes. Yet the dead cells displayed the cytoplasmic features of apoptosis, including cell shrinkage, phosphatidylserine exposure, and decreased mitochondrial transmembrane potential (DeltaPsim). CD47 mAb-induced cell death also occurred in normal resting and activated lymphocytes, with B-CLL cells demonstrating the highest susceptibility. Importantly, iDCs and CD34(+) progenitors were resistant. Structure-function studies in cell lines transfected with various CD47 chimeras demonstrated that killing exclusively required the extracellular and transmembrane domains of the CD47 molecule. Cytochalasin D, an inhibitor of actin polymerization, and antimycin A, an inhibitor of mitochondrial electron transfer, completely suppressed CD47-induced phosphatidylserine exposure. Interestingly, CD47 ligation failed to induce cell death in mononuclear cells isolated from Wiskott-Aldrich syndrome (WAS) patients, suggesting the involvement of Cdc42/WAS protein (WASP) signaling pathway. We propose that CD47-induced caspase-independent cell death be mediated by cytoskeleton reorganization. This form of cell death may be relevant to maintenance of homeostasis and as such might be explored for the development of future therapeutic approaches in lymphoid malignancies.

MeSH Terms
Antibodies, Monoclonal/pharmacology Antigens, CD/immunology Apoptosis/drug effects B-Lymphocytes/immunology Burkitt Lymphoma CD47 Antigen Carrier Proteins/immunology Caspases/metabolism Cell Death/immunology Cytoskeleton/immunology,ultrastructure Enzyme Activation Humans Jurkat Cells Leukemia, Lymphocytic, Chronic, B-Cell/immunology,pathology Necrosis Phagocytosis Phosphatidylserines/pharmacology Reference Values Thrombospondins/pharmacology Transfection Tumor Cells, Cultured U937 Cells Wiskott-Aldrich Syndrome/blood,immunology
Chemicals
Antibodies, Monoclonal Antigens, CD CD47 Antigen CD47 protein, human Carrier Proteins Phosphatidylserines Thrombospondins Caspases
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Mateo Véronique
Centre de Recherche du Centre Hospitalier Université Montreal, Laboratoire d' Immunorégulation, Université de Montréal, Canada.
Brown Eric J
Biron Guy
Rubio Manuel
Fischer Alain
Deist Françoise Le
Sarfati Marika
Article Info
Journal
Blood
Abbr.
Blood
ISSN
0006-4971
Published
2002-10-15
Pages
2882-90
Language
English
Region
United States
NLM ID
7603509
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com